Beta Drugs Ltd.
Snapshot View

365.00 +5.50 ▲1.5%

03 August 2021, 03:02:24 P.M.
Volume: 2,400

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.betadrugslimited.com
Financial Indicators
Market Cap 345.62 Cr.
Earnings per share (EPS) 7.26 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 49.52 Trailing Twelve Months Ending 2021-03
Industry PE 32.66 Trailing Twelve Months Ending 2021-03
Book Value / Share 65.96 Trailing Twelve Months Ending 2021-03
Price to Book Value 5.45 Calculated using Price: 359.50
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.96 Cr. 9,613,790 Shares
FaceValue 10
Company Profile

Company was incorporated as Beta Drugs Private limited at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of Company held on July 24, 2017 and the name of Company was changed to Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh.

Business area of the company

Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases. Beta Drugs is a part of Adley Group, which was founded in the year 1985. Company's manufacturing unit is located at Solan, Himachal Pradesh.

Key events and milestones

  • 2005: Incorporation of Company as Beta Drugs Private Limited
  • 2014: Vijay Kumar Batra, existing promoter took over the Company
  • 2015: ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules.
  • 2015: Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh
  • 2016: Certificate of Good Manufacturing Practice from Republic of Kenya
  • 2017: Conversion of Company into Public Limited Company

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+1.53%
1 Week
-2.93%
1 Month
+5.11%
3 Month
+105.75%
6 Month
+206.85%
1 Year
+356.54%
2 Year
+356.25%
5 Year
8 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 27.67 12.74 -18.28 69.39 103.22 34.73 21.00 14.63
Return on Capital Employed (%) 12.03 8.64 -2.61 21.92 48.91 28.63 18.42 16.85
Return on Assets (%) 2.48 1.39 -2.44 9.77 22.23 18.58 13.41 9.54

Balance Sheet View Details

Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 0 0 1 2 6 33 41 56
Non Curr. Liab. 1 1 4 4 4 3 5 4
Curr. Liab. 1 1 3 9 13 14 19 23
Minority Int.
Equity & Liab. 2 1 8 15 23 50 66 83
Non Curr. Assets 1 1 6 7 8 17 33 45
Curr. Assets 1 1 2 8 15 32 32 38
Misc. Exp. not W/O
Total Assets 2 1 8 15 23 50 66 83

Profit Loss View Details

Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 3 1 0 26 42 51 58 65
Other Income 0 0 0 0 0
Total Income 3 1 0 26 42 51 58 66
Total Expenditure -3 -1 0 -23 -34 -41 -48 -54
PBIDT 0 0 0 3 7 10 11 12
Interest 0 0 0 -1 -1 -1 -1 -1
Depreciation 0 0 0 -1 -1 -2 -2 -3
Taxation -1 0 0 -2
Exceptional Items
PAT 0 0 0 1 4 7 8 7

Cash Flow View Details

Particulars 8 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 5 17 8 6
Cash Fr. Inv. 0 -6 -2 -2 -11 -16 -14
Cash Fr. Finan. 0 0 4 3 -3 5 -1 9
Net Change 0 0 0 12 -9 1
Cash & Cash Eqvt 0 0 0 0 0 12 -9 1

Shareholding Pattern View Details

9 Qtrs 2018-09 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 68.89 69.45 65.32 66.08 66.08 66.61 66.68 66.68 66.68
Public 31.11 30.55 34.68 33.92 33.92 33.39 33.32 33.32 33.33
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

No Corporate Announcement found.

Technical Scans View Details

Mon, 02 Aug 2021
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 185,816.50 795.20 +2.7%
Divi's Laboratories Ltd. 130,822.92 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. 78,219.21 4,719.00 +0.4%
Cipla Ltd. 74,356.30 928.15 +0.7%
Cadila Healthcare Ltd. 60,574.85 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. 58,218.41 4,088.35 +1.0%
Piramal Enterprises Ltd. 56,317.82 2,509.70 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 30.95 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2021-03 65.93 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.02 4,719.00 +0.4%
Cipla Ltd. Consolidated 2021-03 30.92 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 28.39 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 387.19 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 42.27 2,509.70 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.88 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2021-03 14.08 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.37 4,719.00 +0.4%
Cipla Ltd. Consolidated 2021-03 4.06 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 4.66 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.67 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 1.65 2,509.70 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,719.00 +0.4%
Cipla Ltd. Consolidated 2020-03 0.18 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,509.70 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,719.00 +0.4%
Cipla Ltd. Consolidated 2020-03 10.09 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,509.70 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,719.00 +0.4%
Cipla Ltd. Consolidated 2020-03 12.53 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,509.70 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,719.00 +0.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,509.70 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 795.20 +2.7%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 5,011.70 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,719.00 +0.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 928.15 +0.7%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 592.65 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,088.35 +1.0%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,509.70 +0.8%